Growth Metrics

Cerus (CERS) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Cerus 549.42 Mn 469.73 Mn 27.89 Mn 78.65%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 78.65%
Dec 31, 2025 597.76%
Sep 30, 2025 99.32%
Jun 30, 2025 1.04%
Mar 31, 2025 20.35%
Dec 31, 2024 -108.45%
Sep 30, 2024 59.73%
Jun 30, 2024 56.68%
Mar 31, 2024 38.05%
Dec 31, 2023 356.48%
Sep 30, 2023 14.49%
Jun 30, 2023 -58.80%
Mar 31, 2023 -27.33%
Dec 31, 2022 -131.52%
Sep 30, 2022 31.49%
Jun 30, 2022 45.35%
Mar 31, 2022 29.63%
Dec 31, 2021 417.34%
Sep 30, 2021 12.04%
Jun 30, 2021 -3.30%
Mar 31, 2021 -6.02%
Dec 31, 2020 19.58%
Sep 30, 2020 21.31%
Jun 30, 2020 15.32%
Mar 31, 2020 12.38%
Dec 31, 2019 -142.74%
Sep 30, 2019 -26.60%
Jun 30, 2019 -32.22%
Mar 31, 2019 -35.34%
Dec 31, 2018 564.56%
Sep 30, 2018 -5.77%
Jun 30, 2018 22.25%
Mar 31, 2018 25.34%
Dec 31, 2017 35.74%
Sep 30, 2017 6.66%
Jun 30, 2017 5.96%
Mar 31, 2017 -10.29%
Dec 31, 2016 24.54%
Sep 30, 2016 8.32%
Jun 30, 2016 -13.74%
Mar 31, 2016 -78.26%
Dec 31, 2015 -199.08%
Sep 30, 2015 -45.74%
Jun 30, 2015 -110.46%
Mar 31, 2015 -4,104.44%
Dec 31, 2014 419.90%
Sep 30, 2014 47.52%
Jun 30, 2014 -12.86%
Mar 31, 2014 97.81%
Dec 31, 2013 -241.49%
Sep 30, 2013 -373.14%
Jun 30, 2013 -20.48%
Mar 31, 2013 -16.05%
Dec 31, 2012 77.82%
Sep 30, 2012 -291.73%
Jun 30, 2012 12.92%
Mar 31, 2012 -73.28%
Dec 31, 2011 -242.16%
Sep 30, 2011 160.61%
Jun 30, 2011 -64.08%